These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28365812)

  • 1. Serum levels of matrix metalloproteinase-3 and autoantibodies related to rheumatoid arthritis in the general Japanese population and their association with osteoporosis and osteoarthritis: the ROAD study.
    Kodama R; Muraki S; Iidaka T; Oka H; Teraguchi M; Kagotani R; Asai Y; Hashizume H; Yoshida M; Kawaguchi H; Nakamura K; Akune T; Tanaka S; Yoshimura N
    J Bone Miner Metab; 2018 Mar; 36(2):246-253. PubMed ID: 28365812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
    Shovman O; Gilburd B; Zandman-Goddard G; Sherer Y; Orbach H; Gerli R; Shoenfeld Y
    Clin Dev Immunol; 2005 Sep; 12(3):197-202. PubMed ID: 16295525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive association between serum thymic stromal lymphopoietin and anti-citrullinated peptide antibodies in patients with rheumatoid arthritis.
    Koyama K; Ohba T; Haro H; Nakao A
    Clin Exp Immunol; 2015 Aug; 181(2):239-43. PubMed ID: 25817699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic utility of matrix metalloproteinase-3 and high-sensitivity C-reactive protein for predicting rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-negative patients with recent-onset undifferentiated arthritis.
    Hiura K; Iwaki-Egawa S; Kawashima T; Fujisawa S; Takeda T; Komori H; Watanabe Y
    Rheumatol Int; 2013 Sep; 33(9):2309-14. PubMed ID: 23503938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
    Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis.
    Takahashi M; Naito K; Abe M; Sawada T; Nagano A
    Arthritis Res Ther; 2004; 6(3):R208-12. PubMed ID: 15142266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis.
    Xiangyang Z; Lutian Y; Lin Z; Liping X; Hui S; Jing L
    Cytokine; 2012 Apr; 58(1):6-9. PubMed ID: 22239947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New biomarkers for rheumatoid arthritis].
    Hayashi N; Nishimura K; Kumagai S
    Rinsho Byori; 2008 Apr; 56(4):297-308. PubMed ID: 18516964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis.
    Gonzalez SM; Payne JB; Yu F; Thiele GM; Erickson AR; Johnson PG; Schmid MJ; Cannon GW; Kerr GS; Reimold AM; Sokolove J; Robinson WH; Mikuls TR
    J Periodontol; 2015 Feb; 86(2):222-31. PubMed ID: 25299390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatoid Factor, Anti-Cyclic Citrullinated Peptide Antibody, C-Reactive Protein, and Erythrocyte Sedimentation Rate for the Clinical Diagnosis of Rheumatoid Arthritis.
    Shen R; Ren X; Jing R; Shen X; Chen J; Ju S; Yang C
    Lab Med; 2015; 46(3):226-9. PubMed ID: 26199263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Examination of rheumatoid factor and other serum markers in rheumatoid arthritis].
    Hiura K; Iwaki-Egawa S; Matsuno H; Watanabe Y
    Yakugaku Zasshi; 2005 Nov; 125(11):881-7. PubMed ID: 16272809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Interferon-Inducible Protein IFI16 Correlates With Clinical and Serological Features in Rheumatoid Arthritis.
    Alunno A; Caneparo V; Bistoni O; Caterbi S; Terenzi R; Gariglio M; Bartoloni E; Manzo A; Landolfo S; Gerli R
    Arthritis Care Res (Hoboken); 2016 Apr; 68(4):440-5. PubMed ID: 26316393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis.
    Sun X; Zhao J; Liu R; Jia R; Sun L; Li X; Li Z
    Scand J Rheumatol; 2013; 42(2):97-101. PubMed ID: 23311967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis.
    Suzuki K; Sawada T; Murakami A; Matsui T; Tohma S; Nakazono K; Takemura M; Takasaki Y; Mimori T; Yamamoto K
    Scand J Rheumatol; 2003; 32(4):197-204. PubMed ID: 14626625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower expression of histamine H₄ receptor in synovial tissues from patients with rheumatoid arthritis compared to those with osteoarthritis.
    Yamaura K; Oda M; Suzuki M; Ueno K
    Rheumatol Int; 2012 Oct; 32(10):3309-13. PubMed ID: 21881994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
    Us D; Gülmez D; Hasçelik G
    Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
    Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of serum matrix metalloproteinase-3 as a predictive marker for the long-term disability of rheumatoid arthritis patients in a prospective observational cohort IORRA.
    Shinozaki M; Inoue E; Nakajima A; Hara M; Tomatsu T; Kamatani N; Yamanaka H
    Mod Rheumatol; 2007; 17(5):403-8. PubMed ID: 17929133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.